TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 168 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $2,493,000 | +179.8% | 33,136 | -0.2% | 0.00% | +200.0% |
Q1 2022 | $891,000 | -43.7% | 33,190 | +0.1% | 0.00% | -50.0% |
Q4 2021 | $1,582,000 | -46.9% | 33,168 | -26.0% | 0.00% | -33.3% |
Q3 2021 | $2,979,000 | -26.1% | 44,838 | -13.2% | 0.00% | -25.0% |
Q2 2021 | $4,032,000 | -9.8% | 51,684 | +9.3% | 0.00% | -20.0% |
Q1 2021 | $4,472,000 | -34.1% | 47,276 | -15.1% | 0.01% | -37.5% |
Q4 2020 | $6,788,000 | +54.5% | 55,706 | +10.8% | 0.01% | +60.0% |
Q3 2020 | $4,393,000 | +105.9% | 50,281 | +52.2% | 0.01% | +66.7% |
Q2 2020 | $2,134,000 | +51.6% | 33,036 | +4.8% | 0.00% | +50.0% |
Q1 2020 | $1,408,000 | -28.3% | 31,536 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $1,964,000 | +325.1% | 31,536 | +156.9% | 0.00% | +100.0% |
Q3 2019 | $462,000 | -7.6% | 12,276 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $500,000 | – | 12,276 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |